SCHEMBL7185214

SCHEMBL7185214

CCCc1cc(CCC)c(OCC)c(/C=C/C(=O)c2ccc(NC)cc2)c1O

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAOB P27338 7/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
CYP1A1 P04798 4/20 0.39
CYP1B1 Q16678 4/20 0.39
CYP1A2 P05177 3/20 0.39
CYP2D6 P10635 3/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MAOA P21397 1/20 0.38
RAB9A P51151 2/20 0.38
NPC1 O15118 1/20 0.38
CYP3A4 P08684 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7185218 1.00 MAOB (0.40) MAOBABCG2CYP1A1CYP1B1CYP1A2
SCHEMBL7186614 0.93 ABCG2 (0.42) MAOBABCG2CYP1A1CYP1B1MAPT
SCHEMBL7186612 0.93 ABCG2 (0.42) MAOBABCG2CYP1A1CYP1B1MAPT
SCHEMBL7179071 0.90 ABCG2 (0.41) ABCG2MAPTKDM4EALDH1A1LMNA
SCHEMBL7179069 0.90 ABCG2 (0.41) ABCG2MAPTKDM4EALDH1A1LMNA
SCHEMBL7185955 0.90 MAOB (0.42) MAOBABCG2CYP1A1CYP1B1CYP1A2
SCHEMBL7185949 0.90 MAOB (0.42) MAOBABCG2CYP1A1CYP1B1CYP1A2
SCHEMBL7187449 0.89 MAOB (0.51) MAOBABCG2CYP1A1CYP1B1CYP1A2
SCHEMBL7187442 0.89 MAOB (0.51) MAOBABCG2CYP1A1CYP1B1CYP1A2
SCHEMBL7184653 0.88 MAOB (0.38) MAOBABCG2CYP1A1CYP1B1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed